Aurobindo Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2025 ,inter alia, to consider and approve Intimation of Board Meeting for consideration of unaudited Financial Results for the quarter ended June 30, 2025 and Dividend.